Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer
Abstract Purpose The ability of the T‐cell–inflamed gene expression profile (GEP) to predict clinical outcome in esophageal cancer (EC) is unknown. This retrospective observational study assessed the prognostic value of GEP and programmed death ligand 1 (PD‐L1) expression in patients with EC treated...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a9956843ede4de294156aa54a3bb155 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2a9956843ede4de294156aa54a3bb155 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2a9956843ede4de294156aa54a3bb1552021-12-01T04:49:15ZPrognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer2045-763410.1002/cam4.4333https://doaj.org/article/2a9956843ede4de294156aa54a3bb1552021-12-01T00:00:00Zhttps://doi.org/10.1002/cam4.4333https://doaj.org/toc/2045-7634Abstract Purpose The ability of the T‐cell–inflamed gene expression profile (GEP) to predict clinical outcome in esophageal cancer (EC) is unknown. This retrospective observational study assessed the prognostic value of GEP and programmed death ligand 1 (PD‐L1) expression in patients with EC treated in routine clinical practice. Methods Tumor samples of 294 patients from three centers in Denmark, South Korea, and the United States, collected between 2005 and 2017, were included. T‐cell–inflamed GEP score was defined as non‐low or low using a cutoff of −1.54. A combined positive score (CPS) ≥10 was defined as PD‐L1 expression positivity. Associations between overall survival (OS) and GEP status and PD‐L1 expression were explored by Cox proportional hazards models adjusting for age, sex, histology, stage, and performance status. Results Median age was 65 years; 63% of patients had adenocarcinoma (AC) and 37% had squamous cell carcinoma (SCC). Thirty‐six percent of tumors were GEP non‐low, with higher prevalence in AC (46%) than SCC (18%). Twenty‐one percent were PD‐L1–positive: 32% in South Korean samples versus 16% in non‐Asian samples and 26% in SCC versus 18% in AC. GEP scores and PD‐L1 CPS were weakly correlated (Spearman’s R = 0.363). OS was not significantly associated with GEP status (non‐low vs low; adjusted hazard ratio, 0.91 [95% CI, 0.69–1.19]) or PD‐L1 expression status. Conclusion Neither GEP nor PD‐L1 expression was a prognostic marker in Asian and non‐Asian patients with EC.Torben SteinicheSun Young RhaHyun Cheol ChungJeanette Baehr GeorgsenMorten LadekarlMarianne NordsmarkMarie Louise JespersenHyo Song KimHyunki KimCarly FeinLaura H. TangTing WuMatthew J. MartonSenaka PeterDavid P. KelsenGeoffrey KuWileyarticleadenocarcinomaretrospective studysquamous cell carcinomaT‐lymphocytesNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancer Medicine, Vol 10, Iss 23, Pp 8365-8376 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
adenocarcinoma retrospective study squamous cell carcinoma T‐lymphocytes Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
adenocarcinoma retrospective study squamous cell carcinoma T‐lymphocytes Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Torben Steiniche Sun Young Rha Hyun Cheol Chung Jeanette Baehr Georgsen Morten Ladekarl Marianne Nordsmark Marie Louise Jespersen Hyo Song Kim Hyunki Kim Carly Fein Laura H. Tang Ting Wu Matthew J. Marton Senaka Peter David P. Kelsen Geoffrey Ku Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer |
description |
Abstract Purpose The ability of the T‐cell–inflamed gene expression profile (GEP) to predict clinical outcome in esophageal cancer (EC) is unknown. This retrospective observational study assessed the prognostic value of GEP and programmed death ligand 1 (PD‐L1) expression in patients with EC treated in routine clinical practice. Methods Tumor samples of 294 patients from three centers in Denmark, South Korea, and the United States, collected between 2005 and 2017, were included. T‐cell–inflamed GEP score was defined as non‐low or low using a cutoff of −1.54. A combined positive score (CPS) ≥10 was defined as PD‐L1 expression positivity. Associations between overall survival (OS) and GEP status and PD‐L1 expression were explored by Cox proportional hazards models adjusting for age, sex, histology, stage, and performance status. Results Median age was 65 years; 63% of patients had adenocarcinoma (AC) and 37% had squamous cell carcinoma (SCC). Thirty‐six percent of tumors were GEP non‐low, with higher prevalence in AC (46%) than SCC (18%). Twenty‐one percent were PD‐L1–positive: 32% in South Korean samples versus 16% in non‐Asian samples and 26% in SCC versus 18% in AC. GEP scores and PD‐L1 CPS were weakly correlated (Spearman’s R = 0.363). OS was not significantly associated with GEP status (non‐low vs low; adjusted hazard ratio, 0.91 [95% CI, 0.69–1.19]) or PD‐L1 expression status. Conclusion Neither GEP nor PD‐L1 expression was a prognostic marker in Asian and non‐Asian patients with EC. |
format |
article |
author |
Torben Steiniche Sun Young Rha Hyun Cheol Chung Jeanette Baehr Georgsen Morten Ladekarl Marianne Nordsmark Marie Louise Jespersen Hyo Song Kim Hyunki Kim Carly Fein Laura H. Tang Ting Wu Matthew J. Marton Senaka Peter David P. Kelsen Geoffrey Ku |
author_facet |
Torben Steiniche Sun Young Rha Hyun Cheol Chung Jeanette Baehr Georgsen Morten Ladekarl Marianne Nordsmark Marie Louise Jespersen Hyo Song Kim Hyunki Kim Carly Fein Laura H. Tang Ting Wu Matthew J. Marton Senaka Peter David P. Kelsen Geoffrey Ku |
author_sort |
Torben Steiniche |
title |
Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer |
title_short |
Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer |
title_full |
Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer |
title_fullStr |
Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer |
title_full_unstemmed |
Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer |
title_sort |
prognostic significance of t‐cell–inflamed gene expression profile and pd‐l1 expression in patients with esophageal cancer |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/2a9956843ede4de294156aa54a3bb155 |
work_keys_str_mv |
AT torbensteiniche prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT sunyoungrha prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT hyuncheolchung prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT jeanettebaehrgeorgsen prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT mortenladekarl prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT mariannenordsmark prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT marielouisejespersen prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT hyosongkim prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT hyunkikim prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT carlyfein prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT laurahtang prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT tingwu prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT matthewjmarton prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT senakapeter prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT davidpkelsen prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer AT geoffreyku prognosticsignificanceoftcellinflamedgeneexpressionprofileandpdl1expressioninpatientswithesophagealcancer |
_version_ |
1718405715705462784 |